DB18147ExperimentalCell transplant therapies
Firolimogene autotemcel: Overview.
- Also known as
- AUTOLOGOUS CD34+ CELLS ISOLATED FROM BONE MARROW OF NEWLY DIAGNOSED X-LINKED SEVERE COMBINED IMMUNODEFICIENCY (X-SCID) PATIENTS, TRANSDUCED EX VIVO WITH A SELF-INACTIVATING LENTIVIRAL VECTOR, ENCODING CODON-OPTIMIZED HUMAN INTERLEUKIN-2 RECEPTOR SUBUNIT
Resolves to
Compound
Which companies are running trials of Firolimogene autotemcel, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account